Loading...

Documentation of Contraception and Pregnancy When Prescribing Potentially Teratogenic Medications for Reproductive-Age Women

BACKGROUND: Certain medications are identified by the U.S. Food and Drug Administration (FDA) as class D or X because they increase the risk for birth defects if used during pregnancy. OBJECTIVE: To assess pregnancy rates and the frequency of contraceptive counseling documented with prescriptions fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Schwarz, Eleanor Bimla, Postlethwaite, Debbie A., Hung, Yun-Yi, Armstrong, Mary Anne
Format: Artigo
Language:Inglês
Published: 2007
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2941151/
https://ncbi.nlm.nih.gov/pubmed/17876020
Tags: Add Tag
No Tags, Be the first to tag this record!